783 related articles for article (PubMed ID: 27461565)
21. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
22. The n-3 docosapentaenoic acid (DPA): A new player in the n-3 long chain polyunsaturated fatty acid family.
Drouin G; Rioux V; Legrand P
Biochimie; 2019 Apr; 159():36-48. PubMed ID: 30716358
[TBL] [Abstract][Full Text] [Related]
23. Docosapentaenoic acid derived metabolites and mediators - The new world of lipid mediator medicine in a nutshell.
Weylandt KH
Eur J Pharmacol; 2016 Aug; 785():108-115. PubMed ID: 26546723
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of EPA, DPA and DHA on cardio-metabolic risk factors in high-fat diet fed mice.
Guo XF; Sinclair AJ; Kaur G; Li D
Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():47-55. PubMed ID: 29113747
[TBL] [Abstract][Full Text] [Related]
25. Interconversions and distinct metabolic fate of eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in bovine aortic endothelial cells.
Achard F; Bénistant C; Lagarde M
Biochim Biophys Acta; 1995 Apr; 1255(3):260-6. PubMed ID: 7734441
[TBL] [Abstract][Full Text] [Related]
26. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trial.
Martinez GL; Koury JC; Brito F; Fischer RG; Gustafsson A; Figueredo CM
J Periodontal Res; 2014 Apr; 49(2):268-74. PubMed ID: 23721647
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of structured lipids containing medium-chain and omega-3 fatty acids.
Hamam F; Shahidi F
J Agric Food Chem; 2006 Jun; 54(12):4390-6. PubMed ID: 16756372
[TBL] [Abstract][Full Text] [Related]
28. The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease.
Barden AE; Shinde S; Burke V; Puddey IB; Beilin LJ; Irish AB; Watts GF; Mori TA
Prostaglandins Other Lipid Mediat; 2018 May; 136():1-8. PubMed ID: 29577973
[TBL] [Abstract][Full Text] [Related]
29. Effects of the flavonol quercetin and α-linolenic acid on n-3 PUFA status in metabolically healthy men and women: a randomised, double-blinded, placebo-controlled, crossover trial.
Burak C; Wolffram S; Zur B; Langguth P; Fimmers R; Alteheld B; Stehle P; Egert S
Br J Nutr; 2017 Mar; 117(5):698-711. PubMed ID: 28366181
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of tissue deposition of omega-3 fatty acids from polar-lipid rich oil of the microalgae Nannochloropsis oculata with krill oil in rats.
Kagan ML; Levy A; Leikin-Frenkel A
Food Funct; 2015 Jan; 6(1):186-92. PubMed ID: 25360534
[TBL] [Abstract][Full Text] [Related]
31. A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma.
Fussbroich D; Zimmermann K; Göpel A; Eickmeier O; Trischler J; Zielen S; Schubert R; Beermann C
Lipids Health Dis; 2019 Jan; 18(1):16. PubMed ID: 30658644
[TBL] [Abstract][Full Text] [Related]
32. Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation.
Schnebelen C; Viau S; Grégoire S; Joffre C; Creuzot-Garcher CP; Bron AM; Bretillon L; Acar N
Ophthalmic Res; 2009; 41(4):216-24. PubMed ID: 19451735
[TBL] [Abstract][Full Text] [Related]
33. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
34. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
35. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G; Pazos M; García-Egido E; Gallardo JM; Rodríguez I; Cela R; Medina I
J Nutr Biochem; 2015 Nov; 26(11):1385-92. PubMed ID: 26320676
[TBL] [Abstract][Full Text] [Related]
36. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
[TBL] [Abstract][Full Text] [Related]
37. EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.
So J; Wu D; Lichtenstein AH; Tai AK; Matthan NR; Maddipati KR; Lamon-Fava S
Atherosclerosis; 2021 Jan; 316():90-98. PubMed ID: 33303222
[TBL] [Abstract][Full Text] [Related]
38. Short communication: the effects of supplementation of various n-3 fatty acids to late-pregnant dairy cows on plasma fatty acid composition of the newborn calves.
Moallem U; Zachut M
J Dairy Sci; 2012 Jul; 95(7):4055-8. PubMed ID: 22720961
[TBL] [Abstract][Full Text] [Related]
39. Effects of postnatal omega-3 fatty acid supplementation on offspring pro-resolving mediators of inflammation at 6 months and 5 years of age: A double blind, randomized controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():126-132. PubMed ID: 29031390
[TBL] [Abstract][Full Text] [Related]
40. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans.
Brenna JT; Salem N; Sinclair AJ; Cunnane SC;
Prostaglandins Leukot Essent Fatty Acids; 2009; 80(2-3):85-91. PubMed ID: 19269799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
